{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:31:56Z","timestamp":1794439916720,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with sporadic cerebral amyloid angiopathy (sCAA) frequently report cognitive or neuropsychiatric symptoms. The aim of this study is to investigate whether in patients with sCAA, cognitive impairment and neuropsychiatric symptoms are associated with a cerebrospinal fluid (CSF) biomarker profile associated with Alzheimer\u2019s disease (AD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this cross-sectional study, we included participants with sCAA and dementia- and stroke-free, age- and sex-matched controls, who underwent a lumbar puncture, brain MRI, cognitive assessments, and self-administered and informant-based-questionnaires on neuropsychiatric symptoms. CSF phosphorylated\u00a0tau, total\u00a0tau and A\u03b242 levels were used to divide sCAA patients in two groups: CAA with (CAA-AD+) or without a CSF biomarker profile associated with AD (CAA-AD-). Performance on global cognition, specific cognitive domains (episodic memory, working memory, processing speed, verbal fluency, visuoconstruction, and executive functioning), presence and severity of neuropsychiatric symptoms, were compared between groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>sCAA-AD+ (<jats:italic>n<\/jats:italic>=31; mean age: 72 \u00b1 6; 42%, 61% female) and sCAA-AD- (<jats:italic>n<\/jats:italic>=23; 70 \u00b1 5; 42% female) participants did not differ with respect to global cognition or type of affected cognitive domain(s). The number or severity of neuropsychiatric symptoms also did not differ between sCAA-AD+ and sCAA-AD- participants. These results did not change after exclusion of patients without prior ICH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In participants with sCAA, a CSF biomarker profile associated with AD does not impact global cognition or specific cognitive domains, or the presence of neuropsychiatric symptoms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-024-01454-3","type":"journal-article","created":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T10:01:38Z","timestamp":1714816898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The relation of a cerebrospinal fluid profile associated with Alzheimer\u2019s disease with cognitive function and neuropsychiatric symptoms in sporadic cerebral amyloid angiopathy"],"prefix":"10.1186","volume":"16","author":[{"given":"Anna M.","family":"De Kort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanishk","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Bea","family":"Kuiperij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieke","family":"J\u00e4kel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil M.","family":"Tuladhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela M.","family":"Terwindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke J. H.","family":"Wermer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen A. H. R.","family":"Claassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina J. M.","family":"Klijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel M.","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy P. C.","family":"Kessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris H. B. M.","family":"Schreuder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,4]]},"reference":[{"issue":"1","key":"1454_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/alz.12366","volume":"18","author":"L J\u00e4kel","year":"2022","unstructured":"J\u00e4kel L, De Kort AM, Klijn CJM, Schreuder FHBM, Verbeek MM. Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis. Alzheimer\u2019s & Dementia. 2022;18(1):10\u201328.","journal-title":"Alzheimer's & Dementia."},{"issue":"1","key":"1454_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/WCO.0000000000000510","volume":"31","author":"MJH Wermer","year":"2018","unstructured":"Wermer MJH, Greenberg SM. The growing clinical spectrum of cerebral amyloid angiopathy. Current Opinion in Neurology. 2018;31(1):28\u201335.","journal-title":"Current Opinion in Neurology."},{"issue":"8","key":"1454_CR3","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1161\/STROKEAHA.116.012999","volume":"47","author":"NF Case","year":"2016","unstructured":"Case NF, Charlton A, Zwiers A, Batool S, McCreary CR, Hogan DB, et al. Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment. Stroke. 2016;47(8):2010\u20136.","journal-title":"Stroke."},{"issue":"1","key":"1454_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3233\/JAD-150890","volume":"52","author":"L Xiong","year":"2016","unstructured":"Xiong L, Davidsdottir S, Reijmer YD, Shoamanesh A, Roongpiboonsopit D, Thanprasertsuk S, et al. Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit. J Alzheimers Dis. 2016;52(1):171\u20138.","journal-title":"J Alzheimers Dis."},{"issue":"22","key":"1454_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022089","volume":"10","author":"EE Smith","year":"2021","unstructured":"Smith EE, Crites S, Wang M, Charlton A, Zwiers A, Sekhon R, et al. Cerebral Amyloid Angiopathy Is Associated With Emotional Dysregulation, Impulse Dyscontrol, and Apathy. J Am Heart Assoc. 2021;10(22): e022089.","journal-title":"J Am Heart Assoc."},{"issue":"6","key":"1454_CR6","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1161\/STROKEAHA.121.035836","volume":"53","author":"K Malhotra","year":"2022","unstructured":"Malhotra K, Theodorou A, Katsanos AH, Zompola C, Shoamanesh A, Boviatsis E, et al. Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A Systematic Review and Meta-Analysis. Stroke. 2022;53(6):1944\u201353.","journal-title":"Stroke."},{"issue":"15","key":"1454_CR7","doi-asserted-by":"publisher","first-page":"e1975","DOI":"10.1212\/WNL.0000000000011745","volume":"96","author":"D Schoemaker","year":"2021","unstructured":"Schoemaker D, Charidimou A, Zanon Zotin MC, Raposo N, Johnson KA, Sanchez JS, et al. Association of Memory Impairment With Concomitant Tau Pathology in Patients With Cerebral Amyloid Angiopathy. Neurology. 2021;96(15):e1975\u201386.","journal-title":"Neurology."},{"issue":"10","key":"1454_CR8","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1016\/j.neurobiolaging.2015.06.028","volume":"36","author":"WD Brenowitz","year":"2015","unstructured":"Brenowitz WD, Nelson PT, Besser LM, Heller KB, Kukull WA. Cerebral amyloid angiopathy and its co-occurrence with Alzheimer\u2019s disease and other cerebrovascular neuropathologic changes. Neurobiology of Aging. 2015;36(10):2702\u20138.","journal-title":"Neurobiology of Aging."},{"key":"1454_CR9","unstructured":"Krell-Roesch J, Rakusa M, Syrjanen JA, van Harten AC, Lowe VJ, Jack Jr. CR, et al. Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging. Alzheimer's & Dementia.n\/a(n\/a)."},{"issue":"4","key":"1454_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement."},{"issue":"17","key":"1454_CR11","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.0b013e3181dad605","volume":"74","author":"J Linn","year":"2010","unstructured":"Linn J, Halpin A, Demaerel P, Ruhland J, Giese AD, Dichgans M, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology. 2010;74(17):1346\u201350.","journal-title":"Neurology."},{"issue":"2","key":"1454_CR12","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1161\/STROKEAHA.121.035019","volume":"53","author":"EA Koemans","year":"2022","unstructured":"Koemans EA, Voigt S, Rasing I, van Harten TW, Jolink WM, Schreuder FH, et al. Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy. Stroke. 2022;53(2):552\u20137.","journal-title":"Stroke."},{"issue":"1","key":"1454_CR13","doi-asserted-by":"publisher","first-page":"e12132","DOI":"10.1002\/trc2.12132","volume":"7","author":"MD Zwan","year":"2021","unstructured":"Zwan MD, van der Flier WM, Cleutjens S, Schouten TC, Vermunt L, Jutten RJ, et al. Dutch Brain Research Registry for study participant recruitment: Design and first results. Alzheimers Dement (N Y). 2021;7(1):e12132.","journal-title":"Alzheimers Dement (N Y)."},{"issue":"6","key":"1454_CR14","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1080\/13803395.2012.667066","volume":"34","author":"E van den Berg","year":"2012","unstructured":"van den Berg E, Ruis C, Biessels GJ, Kappelle LJ, van Zandvoort MJ. The Telephone Interview for Cognitive Status (Modified): relation with a comprehensive neuropsychological assessment. J Clin Exp Neuropsychol. 2012;34(6):598\u2013605.","journal-title":"J Clin Exp Neuropsychol."},{"issue":"2","key":"1454_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/0891988708328214","volume":"22","author":"SE Cook","year":"2009","unstructured":"Cook SE, Marsiske M, McCoy KJ. The use of the Modified Telephone Interview for Cognitive Status (TICS-M) in the detection of amnestic mild cognitive impairment. Journal of Geriatric Psychiatry and Neurology. 2009;22(2):103\u20139.","journal-title":"Journal of Geriatric Psychiatry and Neurology."},{"key":"1454_CR16","volume-title":"Neuropsychological assessment","author":"MD Lezak","year":"2004","unstructured":"Lezak MD. Neuropsychological assessment. USA: Oxford University Press; 2004."},{"issue":"4","key":"1454_CR17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society. 2005;53(4):695\u20139.","journal-title":"Journal of the American Geriatrics Society."},{"issue":"4","key":"1454_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000270308","volume":"8","author":"F Verhage","year":"1965","unstructured":"Verhage F. Intelligence and age in a Dutch sample. Human Development. 1965;8(4):238\u201345.","journal-title":"Human Development."},{"key":"1454_CR19","unstructured":"UNESCO. International Standard Classification of Education (ISCED 2011). Montreal, QC: UNESCO Institute for Statistics; 2011."},{"key":"1454_CR20","doi-asserted-by":"crossref","unstructured":"de Vent NR, Agelink van Rentergem JA, Schmand BA, Murre JMJ, AC, Huizenga HM. Advanced Neuropsychological Diagnostics Infrastructure (ANDI): A Normative Database Created from Control Datasets.\u00a0Front\u00a0Psychol. 2016;7:1601.","DOI":"10.3389\/fpsyg.2016.01601"},{"issue":"14","key":"1454_CR21","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.3390\/jcm11144059","volume":"11","author":"RP Kessels","year":"2022","unstructured":"Kessels RP, de Vent NR, Bruijnen CJ, Jansen MG, de Jonghe JF, Dijkstra BA, Oosterman JM. Regression-Based Normative Data for the Montreal Cognitive Assessment (MoCA) and Its Memory Index Score (MoCA-MIS) for Individuals Aged 18\u201391. J Clin Med. 2022;11(14):4059.","journal-title":"J Clin Med."},{"issue":"1","key":"1454_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3233\/JAD-2011-101821","volume":"25","author":"EH Trittschuh","year":"2011","unstructured":"Trittschuh EH, Crane PK, Larson EB, Cholerton B, McCormick WC, McCurry SM, et al. Effects of varying diagnostic criteria on prevalence of mild cognitive impairment in a community based sample. J Alzheimers Dis. 2011;25(1):163\u201373.","journal-title":"J Alzheimers Dis."},{"issue":"2","key":"1454_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1176\/jnp.4.2.134","volume":"4","author":"SE Starkstein","year":"1992","unstructured":"Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci. 1992;4(2):134\u20139.","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"1454_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3233\/JAD-150146","volume":"47","author":"BJ Guercio","year":"2015","unstructured":"Guercio BJ, Donovan NJ, Munro CE, Aghjayan SL, Wigman SE, Locascio JJ, et al. The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment. J of Alzheimer\u2019s Dis. 2015;47:421\u201332.","journal-title":"J of Alzheimer's Dis."},{"issue":"12","key":"1454_CR25","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","volume":"44","author":"JL Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308\u201314.","journal-title":"Neurology."},{"issue":"2","key":"1454_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1176\/jnp.12.2.233","volume":"12","author":"Daniel I Kaufer","year":"2000","unstructured":"Kaufer Daniel I, Cummings Jeffrey L, Ketchel Patrick, Smith Vanessa, MacMillan Audrey, Shelley Timothy, et al. Validation of the NPI-Q, a Brief Clinical Form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233\u20139.","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"1454_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2021.118175","volume":"237","author":"K Eckstein","year":"2021","unstructured":"Eckstein K, Bachrata B, Hangel G, Widhalm G, Enzinger C, Barth M, et al. Improved susceptibility weighted imaging at ultra-high field using bipolar multi-echo acquisition and optimized image processing: CLEAR-SWI. Neuroimage. 2021;237: 118175.","journal-title":"Neuroimage."},{"issue":"21","key":"1454_CR28","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1212\/WNL.0b013e3181c34a7d","volume":"73","author":"S Gregoire","year":"2009","unstructured":"Gregoire S, Chaudhary U, Brown M, Yousry T, Kallis C, J\u00e4ger H, Werring D. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology. 2009;73(21):1759\u201366.","journal-title":"Neurology."},{"issue":"8","key":"1454_CR29","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/jamaneurol.2016.0832","volume":"73","author":"A Charidimou","year":"2016","unstructured":"Charidimou A, Martinez-Ramirez S, Reijmer YD, Oliveira-Filho J, Lauer A, Roongpiboonsopit D, et al. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation. JAMA Neurology. 2016;73(8):994\u20131001.","journal-title":"JAMA Neurology."},{"issue":"8","key":"1454_CR30","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurology. 2013;12(8):822\u201338.","journal-title":"Lancet Neurology."},{"issue":"2","key":"1454_CR31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. Am J Roentgenol. 1987;149(2):351\u20136.","journal-title":"Am J Roentgenol"},{"key":"1454_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuroimage.2016.09.011","volume":"143","author":"O Puonti","year":"2016","unstructured":"Puonti O, Iglesias JE, Van Leemput K. Fast and sequence-adaptive whole-brain segmentation using parametric Bayesian modeling. Neuroimage. 2016;143:235\u201349.","journal-title":"Neuroimage."},{"key":"1454_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.arr.2015.08.006","volume":"24","author":"D Tromp","year":"2015","unstructured":"Tromp D, Dufour A, Lithfous S, Pebayle T, Despr\u00e9s O. Episodic memory in normal aging and Alzheimer disease: Insights from imaging and behavioral studies. Ageing Research Reviews. 2015;24:232\u201362.","journal-title":"Ageing Research Reviews."},{"key":"1454_CR34","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3233\/JAD-215208","volume":"87","author":"L Grangeon","year":"2022","unstructured":"Grangeon L, Paquet C, Guey S, Zarea A, Martinaud O, Rotharmel M, et al. Cerebrospinal Fluid Profile of Tau, Phosphorylated Tau, A\u03b2 42, and A\u03b2 40 in Probable Cerebral Amyloid Angiopathy. J Alzheimer\u2019s Dis. 2022;87:791\u2013802.","journal-title":"J Alzheimer's Dis."},{"issue":"1","key":"1454_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13195-021-00817-4","volume":"13","author":"K Delmotte","year":"2021","unstructured":"Delmotte K, Schaeverbeke J, Poesen K, Vandenberghe R. Prognostic value of amyloid\/tau\/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer\u2019s disease. Alzheimer\u2019s Res Therapy. 2021;13(1):84.","journal-title":"Alzheimer's Res Therapy."},{"issue":"1","key":"1454_CR36","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1212\/WNL.0000000000009724","volume":"95","author":"JL Ebenau","year":"2020","unstructured":"Ebenau JL, Timmers T, Wesselman LMP, Verberk IMW, Verfaillie SCJ, Slot RER, et al. ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project. Neurology. 2020;95(1):e46\u201358.","journal-title":"Neurology."},{"issue":"1","key":"1454_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12031","volume":"13","author":"C Eckerstr\u00f6m","year":"2021","unstructured":"Eckerstr\u00f6m C, Svensson J, Kettunen P, Jonsson M, Eckerstr\u00f6m M. Evaluation of the ATN model in a longitudinal memory clinic sample with different underlying disorders. Alzheimers Dement (Amst). 2021;13(1): e12031.","journal-title":"Alzheimers Dement (Amst)."},{"issue":"14","key":"1454_CR38","doi-asserted-by":"publisher","first-page":"e1567","DOI":"10.1212\/WNL.0000000000007248","volume":"92","author":"A Soldan","year":"2019","unstructured":"Soldan A, Pettigrew C, Fagan AM, Schindler SE, Moghekar A, Fowler C, et al. ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes. Neurology. 2019;92(14):e1567\u201379.","journal-title":"Neurology."},{"issue":"6","key":"1454_CR39","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med. 2016;8(6):595\u2013608.","journal-title":"EMBO Mol Med."},{"issue":"20","key":"1454_CR40","volume":"90","author":"K Joonho","year":"2018","unstructured":"Joonho K, Han Kyu N, Jeong-Hyeon S, Hee Jin K, Sang Won S, Joon-Kyung S, Duk LN. Atrophy patterns in cerebral amyloid angiopathy with and without cortical superficial siderosis. Neurology. 2018;90(20): e1751.","journal-title":"Neurology."},{"issue":"12","key":"1454_CR41","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.2967\/jnumed.109.062315","volume":"50","author":"YA Chung","year":"2009","unstructured":"Chung YA, O JH, Kim JY, Ahn KJ. Hypoperfusion and ischemia in cerebral amyloid angiopathy documented by 99mTc-ECD brain perfusion SPECT. J Nucl Med. 2009;50(12):1969\u201374.","journal-title":"J Nucl Med"},{"issue":"22","key":"1454_CR42","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","volume":"85","author":"PA Boyle","year":"2015","unstructured":"Boyle PA, Yu L, Nag S, Leurgans S, Wilson RS, Bennett DA, Schneider JA. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015;85(22):1930\u20136.","journal-title":"Neurology."},{"issue":"7","key":"1454_CR43","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1002\/hbm.23629","volume":"38","author":"YD Reijmer","year":"2017","unstructured":"Reijmer YD, Fotiadis P, Charidimou A, van Veluw SJ, Xiong L, Riley GA, et al. Relationship between white matter connectivity loss and cortical thinning in cerebral amyloid angiopathy. Human Brain Mapping. 2017;38(7):3723\u201331.","journal-title":"Human Brain Mapping."},{"issue":"1","key":"1454_CR44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/brain\/awu316","volume":"138","author":"YD Reijmer","year":"2014","unstructured":"Reijmer YD, Fotiadis P, Martinez-Ramirez S, Salat DH, Schultz A, Shoamanesh A, et al. Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy. Brain. 2014;138(1):179\u201388.","journal-title":"Brain."},{"issue":"4","key":"1454_CR45","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1001\/jamapsychiatry.2021.4363","volume":"79","author":"DP Devanand","year":"2022","unstructured":"Devanand DP, Lee S, Huey ED, Goldberg TE. Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias. JAMA Psychiatry. 2022;79(4):359\u201367.","journal-title":"JAMA Psychiatry."},{"issue":"3","key":"1454_CR46","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/jnnp-2021-327557","volume":"93","author":"G Scopelliti","year":"2022","unstructured":"Scopelliti G, Casolla B, Boulouis G, Kuchcinski G, Moulin S, Leys D, et al. Long-term neuropsychiatric symptoms in spontaneous intracerebral haemorrhage survivors. J Neurol Neurosurg Psychiatry. 2022;93(3):232\u20137.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"6","key":"1454_CR47","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/ana.26610","volume":"93","author":"AM De Kort","year":"2023","unstructured":"De Kort AM, Kuiperij HB, Marques TM, J\u00e4kel L, van den Berg E, Kersten I, et al. Decreased Cerebrospinal Fluid Amyloid \u03b2 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy. Annals of Neurol. 2023;93(6):1173\u201386.","journal-title":"Annals of Neurol."}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01454-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01454-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01454-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T11:02:24Z","timestamp":1714820544000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01454-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,4]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1454"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01454-3","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,4]]},"assertion":[{"value":"26 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lumbar punctures, MRI\u2019s, neuropsychological and neuropsychiatric assessments and other questionnaires were performed after informed consent from the patients and controls. This study was approved by the Medical Ethics Committee Arnhem-Nijmegen and Medical Ethics Committee of Leiden and was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}